Vision

Visionary Pharmaceuticals is a San Diego-based biotechnology company focused on the discovery and development of first-in-class small molecule therapeutics for oncology and autoimmune diseases. The company utilizes its proprietary Bindingsights computational platform and 'Nuclear Receptor and Kinase Knowledge Engine' to identify and optimize high-efficiency ligands for challenging targets. Visionary’s research programs primarily target RORγt for the treatment of inflammatory diseases and SGK1 inhibitors to address tumor resistance and growth in oncology, particularly in triple-negative breast cancer. By integrating cutting-edge computational algorithms with deep expertise in nuclear receptors and kinases, the company aims to significantly accelerate the development of novel oral therapies. Its current pipeline includes candidates for conditions ranging from psoriasis and inflammatory bowel disease to solid tumors.